These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 8292811

  • 1. Measurement of aspartate carbamoyltransferase activity by high performance liquid chromatography.
    Grem JL, Drake JC, Allegra CJ.
    Anticancer Drugs; 1993 Oct; 4(5):545-54. PubMed ID: 8292811
    [Abstract] [Full Text] [Related]

  • 2. N-(Phosphonacetyl)-L-aspartate inhibition of the enzyme complex of pyrimidine biosynthesis.
    Moore EC.
    Biochem Pharmacol; 1982 Oct 15; 31(20):3313-6. PubMed ID: 7150357
    [Abstract] [Full Text] [Related]

  • 3. Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate.
    Moore EC, Friedman J, Valdivieso M, Plunkett W, Marti JR, Russ J, Loo TL.
    Biochem Pharmacol; 1982 Oct 15; 31(20):3317-21. PubMed ID: 7150358
    [Abstract] [Full Text] [Related]

  • 4. In situ properties of Helicobacter pylori aspartate carbamoyltransferase.
    Burns BP, Mendz GL, Hazell SL.
    Arch Biochem Biophys; 1997 Nov 01; 347(1):119-25. PubMed ID: 9344472
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulatory kinetics of wheat-germ aspartate transcarbamoylase. Adaptation of the concerted model to account for complex kinetic effects of uridine 5'-monophosphate.
    Yon RJ.
    Biochem J; 1984 Jul 15; 221(2):281-7. PubMed ID: 6477473
    [Abstract] [Full Text] [Related]

  • 10. Flux through the de novo pyrimidine pathway in vivo. Effect of N-phosphonacetyl-L-aspartate, a potent inhibitor of aspartate transcarbamylase.
    Monks A, Anderson LW, Strong J, Cysyk RL.
    J Biol Chem; 1983 Nov 25; 258(22):13564-9. PubMed ID: 6417130
    [Abstract] [Full Text] [Related]

  • 11. Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA).
    Friedman J, Moore EC, Hall SW, Loo TL.
    Cancer Treat Rep; 1979 Jan 25; 63(1):85-8. PubMed ID: 421235
    [Abstract] [Full Text] [Related]

  • 12. Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells.
    White JC, Hines LH.
    Biochem Pharmacol; 1984 Nov 15; 33(22):3645-8. PubMed ID: 6508821
    [Abstract] [Full Text] [Related]

  • 13. N-(Phosphonacetyl)-L-aspartate (PALA): current status.
    Rozencweig M, Abele R, Piccart M, Von Hoff DD, Muggia FM.
    Recent Results Cancer Res; 1980 Nov 15; 74():72-7. PubMed ID: 7444151
    [Abstract] [Full Text] [Related]

  • 14. Overproduction of the first three enzymes of pyrimidine nucleotide biosynthesis in Drosophila cells resistant to N-phosphonacetyl-L-aspartate.
    Laval M, Azou Y, Giorgi D, Rosset R.
    Exp Cell Res; 1986 Apr 15; 163(2):381-95. PubMed ID: 2869965
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An enzymatic technique for measuring N-phosphonacetyl-L-aspartic acid in tissues.
    Cooney DA, Karlowicz MG, Cubillan J, Roettger M, Jayaram HN.
    Cancer Treat Rep; 1978 Oct 15; 62(10):1503-7. PubMed ID: 361225
    [Abstract] [Full Text] [Related]

  • 18. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
    Kensler TW, Jayaram HN, Cooney DA.
    Adv Enzyme Regul; 1982 Oct 15; 20():57-73. PubMed ID: 7113804
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.